List of tracks for submission

Your session must be submitted under one of the official tracks for the conference:

Note this is to assist with programme planning, track choice has no impact on the selection process.

Track A: Basic and translational research
Scope for this track includes basic sciences, pre-clinical and product development for TB and other lung health conditions
A1. Immunology
A2. Drug and vaccine development, including for COVID-19
A3. TB diagnostics, including drug-resistance determination
A4. COVID-19: molecular and immuno diagnostics
Track B: Clinical and operational research
Scope for this track includes clinical trials, pragmatic trials, operational research on prevention, diagnosis and treatment of TB and other lung health conditions, including post-TB lung disease. Targeted populations may include children or any other age group, vulnerable sub-populations or people living with other co-morbidities.
B1. TB diagnostics
B2. Clinical trials and operational research for new treatments for drug sensitive-TB and drug resistant-TB in adults
B3. Clinical trials and operational research for COPD, pneumonia, asthma and other lung health in adults
B4. Clinical trials and operational research for new treatments for drug sensitive-TB and drug resistant-TB in children
B5. Clinical trials and operational research for COPD, pneumonia, asthma and other lung health in children
B6. Active case finding and contact investigation for TB
B7. Identification and management of TB infection
B8. TB and co-infections: including HIV and diabetes
B9. Lung health (other than TB) and co-morbidities
B10. Tobacco and co-morbidities: including NCDs, TB and HIV
B11. COVID-19: clinical and operational research
Track C: Policies and clinical & programmatic implementation
Scope for this track includes the review and evaluation of global and local policies, clinical practices and programmatic implementation across the spectrum of prevention, diagnosis and treatment of TB and other lung health conditions, including post-TB lung disease; including research on improvement of current policies and practices
C1. TB infection (LTBI)
C2. TB care and treatment in drug sensitive-TB
C3. TB care and treatment in drug resistant-TB
C4. Paediatric TB treatment and care
C5. Paediatric lung disease, excluding TB
C6. Maternal and child health: TB and lung disease
C7. Post-TB lung health
C8. Person-centred care
C9. Access to quality TB care and services
C10. Global and local policies and politics, including funding and accountability
C11. TB laboratory service implementation and operations
C12. TB education and training
C13. Tobacco control and tobacco industry interference
C14. MPOWER for tobacco control
C15. COVID-19: policies and clinical implementation
Track D: Epidemiology
Scope for this track includes all aspects of epidemiology relating to TB, lung disease, tobacco control and co-morbidities such as HIV.
D1. TB epidemiology in adults
D2. TB epidemiology in children
D3. Epidemiology of COPD, pneumonia, asthma and other lung health conditions in adults
D4. Epidemiology of COPD, pneumonia, asthma and other lung health conditions in children
D5. Epidemiology of transmission and latent TB infection (LTBI)
D6. TB infection control
D7. Post-TB lung health
D8. HIV-TB and other HIV-related lung health
D9. Modelling, including modelling of COVID-19: the effect of social controls, preparedness and lessons for other infectious diseases.
D10. Health Economics
D11. Tobacco-related epidemiology
D12. E-cigarettes and non-combustible tobacco products
D13. COVID-19
Track E: Politics, civil society and human rights
Scope includes research on and assessment of social, political, legal and human rights factors, stigma and discrimination influencing prevention, treatment, care and support for persons impacted by lung health issues, as well as communication of these issues to relevant stakeholders.
E1. Civil society, advocacy and community engagement
E2. Key affected populations: behavioural, social, and cultural issues and contexts
E3. Human rights
E4. Ethics
E5. Communication/social media
Track F: Zoonotic TB
Scope for this track includes studies on the epidemiology, prevention, diagnosis, and treatment challenges posed by zoonotic tuberculosis caused primarily by Mycobacterium bovis; to assist animal and public health agencies in more effectively controlling this disease and collaborating on field and laboratory research.
F1. Basic science and zoonotic diagnostics
F2. Zoonotic treatment
F3. Zoonotic epidemiology
F4. One Health

In addition: Europe Track

Would you be interested in presenting your proposal as part of the Europe Track?

Developed in partnership with The Union’s Europe Region, these sessions will focus on the TB and lung health experiences and challenges that are particularly pressing in Europe and typically explored at European Regional Conference.

Back to top

Receive Conference News & Updates